Paul Haluska

Immune-Induced Epithelial to Mesenchymal Transition <i>In vivo</i> Generates Breast Cancer Stem Cells

Marta Santisteban, Jennifer M. Reiman, Michael K. Asiedu et al. · Cancer Research · 2009 · 378 citations · Full text

Breast Oncology, Adult Stem Cell, Immunology +18

Safety, pharmacokinetics, and preliminary activity of the anti-IGF-1R antibody figitumumab (CP-751,871) in patients with sarcoma and Ewing's sarcoma: a phase 1 expansion cohort study

David Olmos, Sophie Postel‐Vinay, L Rhoda Molife et al. · The Lancet Oncology · 2009 · 338 citations · Full text

Anti-igf-1r Antibody Figitumumab, Medicine, Immunology +7

Phase I Trial of Intraperitoneal Administration of an Oncolytic Measles Virus Strain Engineered to Express Carcinoembryonic Antigen for Recurrent Ovarian Cancer

Evanthia Galanis, Lynn C. Hartmann, William A. Cliby et al. · Cancer Research · 2010 · 313 citations · Full text

Intraperitoneal Administration, Synthetic Virology, Immunology +16

Phase I Dose Escalation Study of the Anti–Insulin-Like Growth Factor-I Receptor Monoclonal Antibody CP-751,871 in Patients with Refractory Solid Tumors

Paul Haluska, Heather M. Shaw, Gretchen N. Batzel et al. · Clinical Cancer Research · 2007 · 266 citations

Phase II Study of the Anti–Insulin-Like Growth Factor Type 1 Receptor Antibody CP-751,871 in Combination With Paclitaxel and Carboplatin in Previously Untreated, Locally Advanced, or Metastatic Non–Small-Cell Lung Cancer

Daniel D. Karp, Luis Paz‐Ares, Silvia Novello et al. · Journal of Clinical Oncology · 2009 · 262 citations · Full text